Perspective gets FDA fast track status for radiopharmaceutical VMT01 Source: Seekingalpha
Browsing: Healthcare
Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket Source: Seekingalpha
lcodacci Genetic Leap, an organization targeted on AI-driven drug discovery, introduced Thursday a analysis collaboration price as much as $409M with Eli Lilly (NYSE:LLY) to develop…
Lisata jumps on FDA orphan drug status for liver cancer drug Source: Seekingalpha
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
Kits Eyecare (TSX:KITS:CA) mentioned on Thursday that sure promoting shareholders have entered into an settlement with Canaccord Genuity as sole bookrunner to buy on a purchased…
Ensysce Biosciences announces $5M concurrent providing, shares fall Source: Seekingalpha
P3 Health Partners appoints Leif Pedersen as CFO Source: Seekingalpha